Potential Risks, Side Effects and Safety Concerns Risks include water retention, elevated IGF-1, impaired glucose tolerance, and injection site infection for CJC 1295 and ipamorelin
Intergroup S9900: Surgical and Other Issues
The Phase 3 study evaluated orforglipron, an investigational, once-daily oral small molecule glucagon-like peptide-1 (GLP-1) receptor agonist, for weight maintenance over 52 weeks after initial treatment for 72 weeks with the highest tolerated doses of Wegovy (semaglutide) or Zepbound (tirzepatide), in participants from SURMOUNT-5 who were offered the opportunity to be re-randomized to receive orforglipron or placebo
Pigment spots can appear anywhere on the body and can be caused by various reasons like sun exopsure, age, acne scars, pregnancy/hormonal changes
miRNA signatures and transcriptional regulation of their target genes in vitiligo
Another review of 10 studies published in Frontiers in Nutrition in 2021 concluded that L-Carnitine has a potential but modest effect on weight loss in patients with type 2 diabetes
